Activity in this selectionUnited States · May 31, 2026 · May 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $222M
2 disclosed · full round size, not this investor’s share
Rounds
2 in this selectionTriomicsBuilding AI infrastructure to turn complex cancer records into structured intelligence
Role not disclosedBlitzyAutonomous software development platform that deploys thousands of AI agents to complete enterprise codebases
Role not disclosed